COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update

Related Posts

Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications. Clinical trial participants who took tirzepatide,…

New Zealand Steps Up Plans to Ban Under-16s From Social Media

New Zealand is attempting to match steps in Australia, which late last year passed a law that banned children under the age of 16 from setting up accounts on popular…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

‘We are all in this fight’: B.C. wildfire crews expected to join The Pas fire line on Monday

‘We are all in this fight’: B.C. wildfire crews expected to join The Pas fire line on Monday

Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

25 Best Gifts for Frequent Travelers (2025)

25 Best Gifts for Frequent Travelers (2025)

Multiple divisions in flux after welterweight, women’s flyweight title fights at UFC 315

Multiple divisions in flux after welterweight, women’s flyweight title fights at UFC 315